Recherche
-
Random forests for high-dimensional longitudinal data
(Statistical Methods in Medical Research. vol. 30, n° 1, pp. 166-184, 2020-08-09)Article de revue -
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates
(PLoS ONE. vol. 13, n° 11, pp. e0207794, 2018-11-30)Article de revueLibre accès -
Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors
(BMC Medical Research Methodology. vol. 18, n° 1, pp. 159, 2018-12-04)Article de revueLibre accès -
Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination
(International Journal of Infectious Diseases. vol. 74, pp. 83-96, 2018-09)Article de revueLibre accès -
Visualizing omics and clinical data: Which challenges for dealing with their variety?
(Methods. vol. 132, pp. 3-18, 2018-01-01)Article de revue -
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
(The Lancet Infectious Diseases. vol. 20, n° 5, pp. 585-597, 2020)Article de revue -
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial
(PLoS Pathogens. vol. 16, n° 6, pp. e1008522, 2020-06-26)Article de revueLibre accès -
Controlling IL-7 Injections in HIV-Infected Patients
(Bulletin of Mathematical Biology. vol. 80, n° 9, pp. 2349-2377, 2018-09)Article de revue -
Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial
(AIDS. Official journal of the international AIDS Society. vol. 33, n° 2, pp. 279-284, 2019-02-01)Article de revue -
New insights are game-changers in HIV-2 disease management
(The Lancet HIV. vol. 6, n° 4, pp. e214, 2019-04)Article de revue